Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity

  • ORIGINAL ARTICLE
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) represents a systemic disorder characterized by chronic airflow limitation and an increased inflammatory response of the airways. Comorbidities are frequent in COPD and it is crucial to predict these in early stage for adequate management of COPD. Recent studies have reported that elevated levels of pregnancy-associated plasma protein-A (PAPP-A), a zinc-binding metalloproteinase, detected in patients with asthma, lung cancer, and pulmonary embolism and independently associated with cardiovascular events. We aimed to assess serum PAPP-A levels in COPD and the associations between disease severity. The study population consisted of 75 COPD patients and 35 healthy subjects as a control group. PAPP-A levels were measured by using ultrasensitive enzyme-linked immunosorbent assay. Elevated levels of PAPP-A were observed in patients with COPD on comparison with the controls (p = 0.000). The levels in stage 1 (34.73 ± 22.97) and stage 2 (48.29 ± 53.35) were significantly higher than stage 3 (20.58 ± 22.98) and stage 4 (27.36 ± 21.46) (p = 0.049). Increased PAPP-A levels may be a useful marker in management of COPD that seeks to prevent the development of comorbidities such as adverse cardiovascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vestbo, J., S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, A. Anzueto, et al. 2013. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 187(4): 347–65.

    Article  CAS  PubMed  Google Scholar 

  2. Patel, A.R., and J.R. Hurst. 2011. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Review of Respiratory Medicine 5(5): 647–62.

    Article  PubMed  Google Scholar 

  3. Putcha, N., M.A. Puhan, N.N. Hansel, M.B. Drummond, and C.M. Boyd. 2013. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. Copd 10(3): 324–32.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Divo, M., C. Cote, J.P. de Torres, C. Casanova, J.M. Marin, V. Pinto-Plata, et al. 2012. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 186(2): 155–61.

    Article  PubMed  Google Scholar 

  5. Brekke, P.H., T. Omland, P. Smith, and V. Soyseth. 2008. Underdiagnosis of myocardial infarction in COPD—Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respiratory Medicine 102(9): 1243–7.

    Article  PubMed  Google Scholar 

  6. Curkendall, S.M., C. DeLuise, J.K. Jones, S. Lanes, M.R. Stang, E. Goehring Jr., et al. 2006. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Annals of Epidemiology 16(1): 63–70.

    Article  PubMed  Google Scholar 

  7. Donaldson, G.C., J.R. Hurst, C.J. Smith, R.B. Hubbard, and J.A. Wedzicha. 2010. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 137(5): 1091–7.

    Article  PubMed  Google Scholar 

  8. Finkelstein, J., E. Cha, and S.M. Scharf. 2009. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of Chronic Obstructive Pulmonary Disease 4: 337–49.

    Article  PubMed  PubMed Central  Google Scholar 

  9. McAllister, D.A., J.D. Maclay, N.L. Mills, A. Leitch, P. Reid, R. Carruthers, et al. 2012. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. The European Respiratory Journal 39(5): 1097–103.

    Article  CAS  PubMed  Google Scholar 

  10. Doe, C., M. Bafadhel, S. Siddiqui, D. Desai, V. Mistry, P. Rugman, et al. 2010. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138(5): 1140–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jahnz-Rozyk, K., A. Chcialowski, E. Pirozynska, and A. Rogalewska. 2000. Expression of adhesion molecules LFA-1 (CD11a and ICAM-1 (CD54) on lymphocytes and chemokines IL-8 and MCP-1 concentrations in bronchoalveolar lavage of patients with asthma or chronic obstructive pulmonary disease. Polski merkuriusz lekarski : Organ Polskiego Towarzystwa Lekarskiego 9(52): 649–52.

    CAS  Google Scholar 

  12. MacNee, W. 2013. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Annals of Medicine 45(3): 291–300.

    Article  CAS  PubMed  Google Scholar 

  13. Perlstein, T.S., and R.T. Lee. 2006. Smoking, metalloproteinases, and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2): 250–6.

    Article  CAS  PubMed  Google Scholar 

  14. Sin, D.D., and S.F. Man. 2007. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Canadian Journal of Physiology and Pharmacology 85(1): 141–7.

    Article  CAS  PubMed  Google Scholar 

  15. Heeschen, C., S. Dimmeler, C.W. Hamm, S. Fichtlscherer, M.L. Simoons, and A.M. Zeiher. 2005. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. Journal of the American College of Cardiology 45(2): 229–37.

    Article  CAS  PubMed  Google Scholar 

  16. Lund, J., Q.P. Qin, T. Ilva, K. Pettersson, L.M. Voipio-Pulkki, P. Porela, et al. 2003. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108(16): 1924–6.

    Article  PubMed  Google Scholar 

  17. Conti, E., M. Volpe, C. Carrozza, F. Marzo, C. Zuppi, F. Crea, et al. 2005. Pregnancy-associated plasma protein-A and acute coronary syndromes: cause or consequence? Journal of the American College of Cardiology 46(8): 1583–4. author reply 4-5.

    Article  PubMed  Google Scholar 

  18. Bayes-Genis, A., C.A. Conover, M.T. Overgaard, K.R. Bailey, M. Christiansen, D.R. Holmes Jr., et al. 2001. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. The New England Journal of Medicine 345(14): 1022–9.

    Article  CAS  PubMed  Google Scholar 

  19. Barnes, P.J., and B.R. Celli. 2009. Systemic manifestations and comorbidities of COPD. The European Respiratory Journal 33(5): 1165–85.

    Article  CAS  PubMed  Google Scholar 

  20. Eickhoff, P., A. Valipour, D. Kiss, M. Schreder, L. Cekici, K. Geyer, et al. 2008. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 178(12): 1211–8.

    Article  CAS  PubMed  Google Scholar 

  21. McAllister, D.A., J.D. Maclay, N.L. Mills, G. Mair, J. Miller, D. Anderson, et al. 2007. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 176(12): 1208–14.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Thomsen, M., M. Dahl, P. Lange, J. Vestbo, and B.G. Nordestgaard. 2012. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 186(10): 982–8.

    Article  CAS  PubMed  Google Scholar 

  23. Bulut, I., A. Coskun, A. Ciftci, E. Cetinkaya, G. Altiay, T. Caglar, et al. 2009. Relationship between pregnancy-associated plasma protein-A and lung cancer. The American Journal of the Medical Sciences 337(4): 241–4.

    Article  PubMed  Google Scholar 

  24. Coskun, A., O. Balbay, S. Duran, A.N. Annakkaya, I. Bulut, O. Yavuz, et al. 2007. Pregnancy-associated plasma protein-A and asthma. Advances in Therapy 24(2): 362–7.

    Article  CAS  PubMed  Google Scholar 

  25. Zakiyanov, O., M. Kalousova, M. Kratochvilova, V. Kriha, T. Zima, and V. Tesar. 2012. Determinants of circulating matrix metalloproteinase-2 and pregnancy-associated plasma protein-A in patients with chronic kidney disease. Clinical Laboratory 58(5-6): 471–80.

    CAS  PubMed  Google Scholar 

  26. Fialova, L., M. Kalousova, J. Soukupova, S. Sulkova, M. Merta, E. Jelinkova, et al. 2004. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Kidney & Blood Pressure Research 27(2): 88–95.

    Article  CAS  Google Scholar 

  27. Berk, S., O.T. Dogan, E.I. Aydemir, A. Bingol, S.L. Ozsahin, and I. Akkurt. 2013. Diagnostic usefulness of pregnancy-associated plasma protein-A in suspected pulmonary embolism. Multidisciplinary Respiratory Medicine 8(1): 49.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Iversen, K.K., A.S. Teisner, B. Teisner, A. Kliem, M. Bay, V. Kirk, et al. 2008. Pregnancy-associated plasma protein A in non-cardiac conditions. Clinical Biochemistry 41(7-8): 548–53.

    Article  CAS  PubMed  Google Scholar 

  29. Conti, E., C. Carrozza, E. Capoluongo, M. Volpe, F. Crea, C. Zuppi, et al. 2004. Insulin-like growth factor-1 as a vascular protective factor. Circulation 110(15): 2260–5.

    Article  PubMed  Google Scholar 

  30. Crea, F., and F. Andreotti. 2005. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe? European Heart Journal 26(20): 2075–6.

    Article  CAS  PubMed  Google Scholar 

  31. Apple, F.S., A.H. Wu, J. Mair, J. Ravkilde, M. Panteghini, J. Tate, et al. 2005. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clinical Chemistry 51(5): 810–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethical Standards

This study was supported by the Research Fund of the Abant Izzet Baysal University (project no: 2012.08.03.513)

Author information

Authors and Affiliations

  1. Department of Chest Diseases, Abant Izzet Baysal University School of Medicine, Gölköy, Bolu, Turkey

    Fahrettin Talay, Zehra Asuk Yaşar, Özlem Kar Kurt & Aysel Karği

  2. Department of Biochemistry, Abant Izzet Baysal University School of Medicine, Bolu, Turkey

    Mehmet Tosun

  3. Department of Cardiology, Abant Izzet Baysal University School of Medicine, Bolu, Turkey

    Serkan Öztürk & Mehmet Fatih Özlü

  4. Department of Internal Medicine, Abant Izzet Baysal University School of Medicine, Bolu, Turkey

    Aytekin Alçelik

Authors
  1. Fahrettin Talay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Tosun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zehra Asuk Yaşar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Özlem Kar Kurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aysel Karği
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Serkan Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mehmet Fatih Özlü
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aytekin Alçelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zehra Asuk Yaşar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Talay, F., Tosun, M., Yaşar, Z.A. et al. Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity. Inflammation 39, 1130–1133 (2016). https://doi.org/10.1007/s10753-016-0345-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-016-0345-z

KEY WORDS

Search

Navigation